DPT Vaccines Industry Research Report 2023
Highlights
The global DPT Vaccines market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for DPT Vaccines is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for DPT Vaccines is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of DPT Vaccines include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for DPT Vaccines in 12 Months Below is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, DTaP, which accounted for % of the global market of DPT Vaccines in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DPT Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccines.
The DPT Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global DPT Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DPT Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by DPT Vaccines type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the DPT Vaccines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
DPT Vaccines segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the DPT Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the DPT Vaccines market.
DPT Vaccines segment by Age
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the DPT Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the DPT Vaccines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of DPT Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of DPT Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The global DPT Vaccines market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for DPT Vaccines is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for DPT Vaccines is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of DPT Vaccines include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for DPT Vaccines in 12 Months Below is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, DTaP, which accounted for % of the global market of DPT Vaccines in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DPT Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccines.
The DPT Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global DPT Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DPT Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
Global markets are presented by DPT Vaccines type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the DPT Vaccines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
DPT Vaccines segment by Type
- DTaP
- Tdap
- DTwP
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the DPT Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the DPT Vaccines market.
DPT Vaccines segment by Age
- 12 Months Below
- 12 Months Above
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the DPT Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the DPT Vaccines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of DPT Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of DPT Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global DPT Vaccines Market Size (2018-2029) & (US$ Million)
2.2.2 Global DPT Vaccines Sales (2018-2029)
2.2.3 Global DPT Vaccines Market Average Price (2018-2029)
2.3 DPT Vaccines by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
2.4 DPT Vaccines by Age
2.4.1 Market Value Comparison by Age (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 12 Months Below
2.4.3 12 Months Above
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global DPT Vaccines Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global DPT Vaccines Sales (M Doses) of Manufacturers (2018-2023)
3.3 Global DPT Vaccines Revenue of Manufacturers (2018-2023)
3.4 Global DPT Vaccines Average Price by Manufacturers (2018-2023)
3.5 Global DPT Vaccines Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of DPT Vaccines, Product Type & Application
3.8 Global Manufacturers of DPT Vaccines, Date of Enter into This Industry
3.9 Global DPT Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Business Overview
4.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
4.1.5 Sanofi Pasteur Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.2.4 GSK DPT Vaccines Product Portfolio
4.2.5 GSK Recent Developments
4.3 Mitsubishi Tanabe Pharma
4.3.1 Mitsubishi Tanabe Pharma Company Information
4.3.2 Mitsubishi Tanabe Pharma Business Overview
4.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
4.3.5 Mitsubishi Tanabe Pharma Recent Developments
4.4 KM Biologics
4.4.1 KM Biologics Company Information
4.4.2 KM Biologics Business Overview
4.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.4.4 KM Biologics DPT Vaccines Product Portfolio
4.4.5 KM Biologics Recent Developments
4.5 Wuhan Institute of Biological Products
4.5.1 Wuhan Institute of Biological Products Company Information
4.5.2 Wuhan Institute of Biological Products Business Overview
4.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments
4.6 Walvax Biotechnology
4.6.1 Walvax Biotechnology Company Information
4.6.2 Walvax Biotechnology Business Overview
4.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
4.6.5 Walvax Biotechnology Recent Developments
4.7 Chengdu Institute of Biological Products
4.7.1 Chengdu Institute of Biological Products Company Information
4.7.2 Chengdu Institute of Biological Products Business Overview
4.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
4.7.5 Chengdu Institute of Biological Products Recent Developments
6.8 Minhai Biotechnology
4.8.1 Minhai Biotechnology Company Information
4.8.2 Minhai Biotechnology Business Overview
4.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
4.8.5 Minhai Biotechnology Recent Developments
5 GLOBAL DPT VACCINES MARKET SCENARIO BY REGION
5.1 Global DPT Vaccines Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global DPT Vaccines Sales by Region: 2018-2029
5.2.1 Global DPT Vaccines Sales by Region: 2018-2023
5.2.2 Global DPT Vaccines Sales by Region: 2024-2029
5.3 Global DPT Vaccines Revenue by Region: 2018-2029
5.3.1 Global DPT Vaccines Revenue by Region: 2018-2023
5.3.2 Global DPT Vaccines Revenue by Region: 2024-2029
5.4 North America DPT Vaccines Market Facts & Figures by Country
5.4.1 North America DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America DPT Vaccines Sales by Country (2018-2029)
5.4.3 North America DPT Vaccines Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe DPT Vaccines Market Facts & Figures by Country
5.5.1 Europe DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe DPT Vaccines Sales by Country (2018-2029)
5.5.3 Europe DPT Vaccines Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific DPT Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific DPT Vaccines Sales by Country (2018-2029)
5.6.3 Asia Pacific DPT Vaccines Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America DPT Vaccines Market Facts & Figures by Country
5.7.1 Latin America DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America DPT Vaccines Sales by Country (2018-2029)
5.7.3 Latin America DPT Vaccines Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa DPT Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa DPT Vaccines Sales by Country (2018-2029)
5.8.3 Middle East and Africa DPT Vaccines Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global DPT Vaccines Sales by Type (2018-2029)
6.1.1 Global DPT Vaccines Sales by Type (2018-2029) & (M Doses)
6.1.2 Global DPT Vaccines Sales Market Share by Type (2018-2029)
6.2 Global DPT Vaccines Revenue by Type (2018-2029)
6.2.1 Global DPT Vaccines Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global DPT Vaccines Revenue Market Share by Type (2018-2029)
6.3 Global DPT Vaccines Price by Type (2018-2029)
7 SEGMENT BY AGE
7.1 Global DPT Vaccines Sales by Age (2018-2029)
7.1.1 Global DPT Vaccines Sales by Age (2018-2029) & (M Doses)
7.1.2 Global DPT Vaccines Sales Market Share by Age (2018-2029)
7.2 Global DPT Vaccines Revenue by Age (2018-2029)
6.2.1 Global DPT Vaccines Sales by Age (2018-2029) & (US$ Million)
6.2.2 Global DPT Vaccines Revenue Market Share by Age (2018-2029)
7.3 Global DPT Vaccines Price by Age (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 DPT Vaccines Value Chain Analysis
8.1.1 DPT Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 DPT Vaccines Production Mode & Process
8.2 DPT Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 DPT Vaccines Distributors
8.2.3 DPT Vaccines Customers
9 GLOBAL DPT VACCINES ANALYZING MARKET DYNAMICS
9.1 DPT Vaccines Industry Trends
9.2 DPT Vaccines Industry Drivers
9.3 DPT Vaccines Industry Opportunities and Challenges
9.4 DPT Vaccines Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global DPT Vaccines Market Size (2018-2029) & (US$ Million)
2.2.2 Global DPT Vaccines Sales (2018-2029)
2.2.3 Global DPT Vaccines Market Average Price (2018-2029)
2.3 DPT Vaccines by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
2.4 DPT Vaccines by Age
2.4.1 Market Value Comparison by Age (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 12 Months Below
2.4.3 12 Months Above
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global DPT Vaccines Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global DPT Vaccines Sales (M Doses) of Manufacturers (2018-2023)
3.3 Global DPT Vaccines Revenue of Manufacturers (2018-2023)
3.4 Global DPT Vaccines Average Price by Manufacturers (2018-2023)
3.5 Global DPT Vaccines Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of DPT Vaccines, Product Type & Application
3.8 Global Manufacturers of DPT Vaccines, Date of Enter into This Industry
3.9 Global DPT Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Business Overview
4.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
4.1.5 Sanofi Pasteur Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.2.4 GSK DPT Vaccines Product Portfolio
4.2.5 GSK Recent Developments
4.3 Mitsubishi Tanabe Pharma
4.3.1 Mitsubishi Tanabe Pharma Company Information
4.3.2 Mitsubishi Tanabe Pharma Business Overview
4.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
4.3.5 Mitsubishi Tanabe Pharma Recent Developments
4.4 KM Biologics
4.4.1 KM Biologics Company Information
4.4.2 KM Biologics Business Overview
4.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.4.4 KM Biologics DPT Vaccines Product Portfolio
4.4.5 KM Biologics Recent Developments
4.5 Wuhan Institute of Biological Products
4.5.1 Wuhan Institute of Biological Products Company Information
4.5.2 Wuhan Institute of Biological Products Business Overview
4.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments
4.6 Walvax Biotechnology
4.6.1 Walvax Biotechnology Company Information
4.6.2 Walvax Biotechnology Business Overview
4.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
4.6.5 Walvax Biotechnology Recent Developments
4.7 Chengdu Institute of Biological Products
4.7.1 Chengdu Institute of Biological Products Company Information
4.7.2 Chengdu Institute of Biological Products Business Overview
4.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
4.7.5 Chengdu Institute of Biological Products Recent Developments
6.8 Minhai Biotechnology
4.8.1 Minhai Biotechnology Company Information
4.8.2 Minhai Biotechnology Business Overview
4.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
4.8.5 Minhai Biotechnology Recent Developments
5 GLOBAL DPT VACCINES MARKET SCENARIO BY REGION
5.1 Global DPT Vaccines Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global DPT Vaccines Sales by Region: 2018-2029
5.2.1 Global DPT Vaccines Sales by Region: 2018-2023
5.2.2 Global DPT Vaccines Sales by Region: 2024-2029
5.3 Global DPT Vaccines Revenue by Region: 2018-2029
5.3.1 Global DPT Vaccines Revenue by Region: 2018-2023
5.3.2 Global DPT Vaccines Revenue by Region: 2024-2029
5.4 North America DPT Vaccines Market Facts & Figures by Country
5.4.1 North America DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America DPT Vaccines Sales by Country (2018-2029)
5.4.3 North America DPT Vaccines Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe DPT Vaccines Market Facts & Figures by Country
5.5.1 Europe DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe DPT Vaccines Sales by Country (2018-2029)
5.5.3 Europe DPT Vaccines Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific DPT Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific DPT Vaccines Sales by Country (2018-2029)
5.6.3 Asia Pacific DPT Vaccines Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America DPT Vaccines Market Facts & Figures by Country
5.7.1 Latin America DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America DPT Vaccines Sales by Country (2018-2029)
5.7.3 Latin America DPT Vaccines Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa DPT Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa DPT Vaccines Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa DPT Vaccines Sales by Country (2018-2029)
5.8.3 Middle East and Africa DPT Vaccines Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global DPT Vaccines Sales by Type (2018-2029)
6.1.1 Global DPT Vaccines Sales by Type (2018-2029) & (M Doses)
6.1.2 Global DPT Vaccines Sales Market Share by Type (2018-2029)
6.2 Global DPT Vaccines Revenue by Type (2018-2029)
6.2.1 Global DPT Vaccines Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global DPT Vaccines Revenue Market Share by Type (2018-2029)
6.3 Global DPT Vaccines Price by Type (2018-2029)
7 SEGMENT BY AGE
7.1 Global DPT Vaccines Sales by Age (2018-2029)
7.1.1 Global DPT Vaccines Sales by Age (2018-2029) & (M Doses)
7.1.2 Global DPT Vaccines Sales Market Share by Age (2018-2029)
7.2 Global DPT Vaccines Revenue by Age (2018-2029)
6.2.1 Global DPT Vaccines Sales by Age (2018-2029) & (US$ Million)
6.2.2 Global DPT Vaccines Revenue Market Share by Age (2018-2029)
7.3 Global DPT Vaccines Price by Age (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 DPT Vaccines Value Chain Analysis
8.1.1 DPT Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 DPT Vaccines Production Mode & Process
8.2 DPT Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 DPT Vaccines Distributors
8.2.3 DPT Vaccines Customers
9 GLOBAL DPT VACCINES ANALYZING MARKET DYNAMICS
9.1 DPT Vaccines Industry Trends
9.2 DPT Vaccines Industry Drivers
9.3 DPT Vaccines Industry Opportunities and Challenges
9.4 DPT Vaccines Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Age (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global DPT Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global DPT Vaccines Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global DPT Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 8. Global DPT Vaccines Revenue of Manufacturers (2018-2023)
Table 9. Global DPT Vaccines Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market DPT Vaccines Average Price (US$/Dose) of Manufacturers (2018-2023)
Table 11. Global DPT Vaccines Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of DPT Vaccines, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DPT Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Sanofi Pasteur Company Information
Table 17. Sanofi Pasteur Business Overview
Table 18. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 19. Sanofi Pasteur DPT Vaccines Product Portfolio
Table 20. Sanofi Pasteur Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 24. GSK DPT Vaccines Product Portfolio
Table 25. GSK Recent Developments
Table 26. Mitsubishi Tanabe Pharma Company Information
Table 27. Mitsubishi Tanabe Pharma Business Overview
Table 28. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 29. Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
Table 30. Mitsubishi Tanabe Pharma Recent Developments
Table 31. KM Biologics Company Information
Table 32. KM Biologics Business Overview
Table 33. KM Biologics DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 34. KM Biologics DPT Vaccines Product Portfolio
Table 35. KM Biologics Recent Developments
Table 36. Wuhan Institute of Biological Products Company Information
Table 37. Wuhan Institute of Biological Products Business Overview
Table 38. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 39. Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
Table 40. Wuhan Institute of Biological Products Recent Developments
Table 41. Walvax Biotechnology Company Information
Table 42. Walvax Biotechnology Business Overview
Table 43. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 44. Walvax Biotechnology DPT Vaccines Product Portfolio
Table 45. Walvax Biotechnology Recent Developments
Table 46. Chengdu Institute of Biological Products Company Information
Table 47. Chengdu Institute of Biological Products Business Overview
Table 48. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 49. Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
Table 50. Chengdu Institute of Biological Products Recent Developments
Table 51. Minhai Biotechnology Company Information
Table 52. Minhai Biotechnology Business Overview
Table 53. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 54. Minhai Biotechnology DPT Vaccines Product Portfolio
Table 55. Minhai Biotechnology Recent Developments
Table 56. Global DPT Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Global DPT Vaccines Sales by Region (2018-2023) & (M Doses)
Table 58. Global DPT Vaccines Sales Market Share by Region (2018-2023)
Table 59. Global DPT Vaccines Sales by Region (2024-2029) & (M Doses)
Table 60. Global DPT Vaccines Sales Market Share by Region (2024-2029)
Table 61. Global DPT Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 62. Global DPT Vaccines Revenue Market Share by Region (2018-2023)
Table 63. Global DPT Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 64. Global DPT Vaccines Revenue Market Share by Region (2024-2029)
Table 65. North America DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. North America DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 67. North America DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 68. North America DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 69. North America DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 70. Europe DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 72. Europe DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 73. Europe DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 75. Asia Pacific DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Asia Pacific DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 77. Asia Pacific DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 78. Asia Pacific DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 79. Asia Pacific DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 80. Latin America DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Latin America DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 82. Latin America DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 83. Latin America DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 84. Latin America DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 85. Middle East and Africa DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Middle East and Africa DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 87. Middle East and Africa DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 88. Middle East and Africa DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 89. Middle East and Africa DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 90. Global DPT Vaccines Sales by Type (2018-2023) & (M Doses)
Table 91. Global DPT Vaccines Sales by Type (2024-2029) & (M Doses)
Table 92. Global DPT Vaccines Sales Market Share by Type (2018-2023)
Table 93. Global DPT Vaccines Sales Market Share by Type (2024-2029)
Table 94. Global DPT Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 95. Global DPT Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 96. Global DPT Vaccines Revenue Market Share by Type (2018-2023)
Table 97. Global DPT Vaccines Revenue Market Share by Type (2024-2029)
Table 98. Global DPT Vaccines Price by Type (2018-2023) & (US$/Dose)
Table 99. Global DPT Vaccines Price by Type (2024-2029) & (US$/Dose)
Table 100. Global DPT Vaccines Sales by Age (2018-2023) & (M Doses)
Table 101. Global DPT Vaccines Sales by Age (2024-2029) & (M Doses)
Table 102. Global DPT Vaccines Sales Market Share by Age (2018-2023)
Table 103. Global DPT Vaccines Sales Market Share by Age (2024-2029)
Table 104. Global DPT Vaccines Revenue by Age (2018-2023) & (US$ Million)
Table 105. Global DPT Vaccines Revenue by Age (2024-2029) & (US$ Million)
Table 106. Global DPT Vaccines Revenue Market Share by Age (2018-2023)
Table 107. Global DPT Vaccines Revenue Market Share by Age (2024-2029)
Table 108. Global DPT Vaccines Price by Age (2018-2023) & (US$/Dose)
Table 109. Global DPT Vaccines Price by Age (2024-2029) & (US$/Dose)
Table 110. Key Raw Materials
Table 111. Raw Materials Key Suppliers
Table 112. DPT Vaccines Distributors List
Table 113. DPT Vaccines Customers List
Table 114. DPT Vaccines Industry Trends
Table 115. DPT Vaccines Industry Drivers
Table 116. DPT Vaccines Industry Restraints
Table 117. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Age (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global DPT Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global DPT Vaccines Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global DPT Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 8. Global DPT Vaccines Revenue of Manufacturers (2018-2023)
Table 9. Global DPT Vaccines Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market DPT Vaccines Average Price (US$/Dose) of Manufacturers (2018-2023)
Table 11. Global DPT Vaccines Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of DPT Vaccines, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DPT Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Sanofi Pasteur Company Information
Table 17. Sanofi Pasteur Business Overview
Table 18. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 19. Sanofi Pasteur DPT Vaccines Product Portfolio
Table 20. Sanofi Pasteur Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 24. GSK DPT Vaccines Product Portfolio
Table 25. GSK Recent Developments
Table 26. Mitsubishi Tanabe Pharma Company Information
Table 27. Mitsubishi Tanabe Pharma Business Overview
Table 28. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 29. Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
Table 30. Mitsubishi Tanabe Pharma Recent Developments
Table 31. KM Biologics Company Information
Table 32. KM Biologics Business Overview
Table 33. KM Biologics DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 34. KM Biologics DPT Vaccines Product Portfolio
Table 35. KM Biologics Recent Developments
Table 36. Wuhan Institute of Biological Products Company Information
Table 37. Wuhan Institute of Biological Products Business Overview
Table 38. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 39. Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
Table 40. Wuhan Institute of Biological Products Recent Developments
Table 41. Walvax Biotechnology Company Information
Table 42. Walvax Biotechnology Business Overview
Table 43. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 44. Walvax Biotechnology DPT Vaccines Product Portfolio
Table 45. Walvax Biotechnology Recent Developments
Table 46. Chengdu Institute of Biological Products Company Information
Table 47. Chengdu Institute of Biological Products Business Overview
Table 48. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 49. Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
Table 50. Chengdu Institute of Biological Products Recent Developments
Table 51. Minhai Biotechnology Company Information
Table 52. Minhai Biotechnology Business Overview
Table 53. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 54. Minhai Biotechnology DPT Vaccines Product Portfolio
Table 55. Minhai Biotechnology Recent Developments
Table 56. Global DPT Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Global DPT Vaccines Sales by Region (2018-2023) & (M Doses)
Table 58. Global DPT Vaccines Sales Market Share by Region (2018-2023)
Table 59. Global DPT Vaccines Sales by Region (2024-2029) & (M Doses)
Table 60. Global DPT Vaccines Sales Market Share by Region (2024-2029)
Table 61. Global DPT Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 62. Global DPT Vaccines Revenue Market Share by Region (2018-2023)
Table 63. Global DPT Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 64. Global DPT Vaccines Revenue Market Share by Region (2024-2029)
Table 65. North America DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. North America DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 67. North America DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 68. North America DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 69. North America DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 70. Europe DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 72. Europe DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 73. Europe DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 75. Asia Pacific DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Asia Pacific DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 77. Asia Pacific DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 78. Asia Pacific DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 79. Asia Pacific DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 80. Latin America DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Latin America DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 82. Latin America DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 83. Latin America DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 84. Latin America DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 85. Middle East and Africa DPT Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Middle East and Africa DPT Vaccines Sales by Country (2018-2023) & (M Doses)
Table 87. Middle East and Africa DPT Vaccines Sales by Country (2024-2029) & (M Doses)
Table 88. Middle East and Africa DPT Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 89. Middle East and Africa DPT Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 90. Global DPT Vaccines Sales by Type (2018-2023) & (M Doses)
Table 91. Global DPT Vaccines Sales by Type (2024-2029) & (M Doses)
Table 92. Global DPT Vaccines Sales Market Share by Type (2018-2023)
Table 93. Global DPT Vaccines Sales Market Share by Type (2024-2029)
Table 94. Global DPT Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 95. Global DPT Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 96. Global DPT Vaccines Revenue Market Share by Type (2018-2023)
Table 97. Global DPT Vaccines Revenue Market Share by Type (2024-2029)
Table 98. Global DPT Vaccines Price by Type (2018-2023) & (US$/Dose)
Table 99. Global DPT Vaccines Price by Type (2024-2029) & (US$/Dose)
Table 100. Global DPT Vaccines Sales by Age (2018-2023) & (M Doses)
Table 101. Global DPT Vaccines Sales by Age (2024-2029) & (M Doses)
Table 102. Global DPT Vaccines Sales Market Share by Age (2018-2023)
Table 103. Global DPT Vaccines Sales Market Share by Age (2024-2029)
Table 104. Global DPT Vaccines Revenue by Age (2018-2023) & (US$ Million)
Table 105. Global DPT Vaccines Revenue by Age (2024-2029) & (US$ Million)
Table 106. Global DPT Vaccines Revenue Market Share by Age (2018-2023)
Table 107. Global DPT Vaccines Revenue Market Share by Age (2024-2029)
Table 108. Global DPT Vaccines Price by Age (2018-2023) & (US$/Dose)
Table 109. Global DPT Vaccines Price by Age (2024-2029) & (US$/Dose)
Table 110. Key Raw Materials
Table 111. Raw Materials Key Suppliers
Table 112. DPT Vaccines Distributors List
Table 113. DPT Vaccines Customers List
Table 114. DPT Vaccines Industry Trends
Table 115. DPT Vaccines Industry Drivers
Table 116. DPT Vaccines Industry Restraints
Table 117. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. DPT VaccinesProduct Picture
Figure 5. Global DPT Vaccines Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global DPT Vaccines Market Size (2018-2029) & (US$ Million)
Figure 7. Global DPT Vaccines Sales (2018-2029) & (M Doses)
Figure 8. Global DPT Vaccines Average Price (US$/Dose) & (2018-2029)
Figure 9. DTaP Product Picture
Figure 10. Tdap Product Picture
Figure 11. DTwP Product Picture
Figure 12. 12 Months Below Product Picture
Figure 13. 12 Months Above Product Picture
Figure 14. Global DPT Vaccines Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of DPT Vaccines, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 DPT Vaccines Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global DPT Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global DPT Vaccines Sales by Region in 2022
Figure 21. Global DPT Vaccines Revenue by Region in 2022
Figure 22. North America DPT Vaccines Market Size by Country in 2022
Figure 23. North America DPT Vaccines Sales Market Share by Country (2018-2029)
Figure 24. North America DPT Vaccines Revenue Market Share by Country (2018-2029)
Figure 25. United States DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe DPT Vaccines Market Size by Country in 2022
Figure 28. Europe DPT Vaccines Sales Market Share by Country (2018-2029)
Figure 29. Europe DPT Vaccines Revenue Market Share by Country (2018-2029)
Figure 30. Germany DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific DPT Vaccines Market Size by Country in 2022
Figure 36. Asia Pacific DPT Vaccines Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific DPT Vaccines Revenue Market Share by Country (2018-2029)
Figure 38. China DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America DPT Vaccines Market Size by Country in 2022
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. DPT VaccinesProduct Picture
Figure 5. Global DPT Vaccines Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global DPT Vaccines Market Size (2018-2029) & (US$ Million)
Figure 7. Global DPT Vaccines Sales (2018-2029) & (M Doses)
Figure 8. Global DPT Vaccines Average Price (US$/Dose) & (2018-2029)
Figure 9. DTaP Product Picture
Figure 10. Tdap Product Picture
Figure 11. DTwP Product Picture
Figure 12. 12 Months Below Product Picture
Figure 13. 12 Months Above Product Picture
Figure 14. Global DPT Vaccines Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of DPT Vaccines, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 DPT Vaccines Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global DPT Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global DPT Vaccines Sales by Region in 2022
Figure 21. Global DPT Vaccines Revenue by Region in 2022
Figure 22. North America DPT Vaccines Market Size by Country in 2022
Figure 23. North America DPT Vaccines Sales Market Share by Country (2018-2029)
Figure 24. North America DPT Vaccines Revenue Market Share by Country (2018-2029)
Figure 25. United States DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe DPT Vaccines Market Size by Country in 2022
Figure 28. Europe DPT Vaccines Sales Market Share by Country (2018-2029)
Figure 29. Europe DPT Vaccines Revenue Market Share by Country (2018-2029)
Figure 30. Germany DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific DPT Vaccines Market Size by Country in 2022
Figure 36. Asia Pacific DPT Vaccines Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific DPT Vaccines Revenue Market Share by Country (2018-2029)
Figure 38. China DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia DPT Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America DPT Vaccines Market Size by Country in 2022
